Cross-asset strategy: This week’s Fed reiteration that it won’t hike for about three years despite extraordinary fiscal stimulus is extending the repricing of risk premia across financial markets. For us, the direction of risk premia is unambiguously higher in Bonds (high breakevens, steeper curves), but lower in Equities, HY Credit and Commodities (less earnings, default and inventory risk) and…
J.P. Morgan: The other sting in the tail from fiscal policy; higher taxes and the Value rotation
A financial market resource for the every-day investor and trader.
-
-
Can September “Get Right”
Seth Golden, , Research Reports, 0
The first rate cut is out of the way, but most were denying the majority probability spelling out a...
-
Yield Curve Rhetoric: Mounting Fear?
Seth Golden, , Research Reports, 0
Good Sunday morning to all Finom Group subscribers! This week’s research reporting is delivered to subscribers with an emphasis...
-
An Easing Cycle Begins: Tactical Approach For Investors And Traders Alike
Seth Golden, , Research Reports, 0
Welcome Finom Group investors and traders! During our off-reporting weekend, we offer the latest insights and analysis from Wall...
-
Recovering, Not Yet Recovered
Seth Golden, , Research Reports, 0
Welcome back ladies and gentlemen! This weekend’s Research Report will be abbreviated, as we maintain our outlook for 2024,...
-
Weekly State of the Market: Yield Boon, Tech/Growth Swoon
Seth Golden, , Research Reports, 0
“In this business, if you’re good, you’re right six times out of ten. You’re never going to be right...
-
Weekly State of the Market: Follow The Data Into Year-End
Seth Golden, , Research Reports, 0
“Nobody can catch all the fluctuations. In a bull market your game is to buy and hold until you...
-
Weekly State of the Market: Holding Historic Precedence
Seth Golden, , Research Reports, 0
In my conversations over the years with retail investors — many of whom are novices (not that there’s anything...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00